[{"address1": "700 Quince Orchard Road", "city": "Gaithersburg", "state": "MD", "zip": "20878", "country": "United States", "phone": "240 268 2000", "website": "https://www.novavax.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Novavax, Inc., a biotechnology company, engages in the discovering, developing, and commercializing vaccines to protect against serious infectious diseases in the United States, Europe, and internationally. The company offers vaccine platform that combines a recombinant protein approach, nanoparticle technology, and its patented Matrix-M adjuvant to enhance the immune response. The company is commercializing a COVID-19 vaccine, NVX-CoV2373 under the brand names of Nuvaxovid, Covovax, and Novavax COVID-19 Vaccine, adjuvanted for adult and adolescent populations as a primary series and for both homologous and heterologous booster indications. It also developing R21/Matrix-M adjuvant malaria vaccine. Novavax, Inc. was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.", "fullTimeEmployees": 952, "companyOfficers": [{"maxAge": 1, "name": "Mr. John Charles Jacobs M.B.A.", "age": 57, "title": "President, CEO & Director", "yearBorn": 1967, "fiscalYear": 2024, "totalPay": 1550611, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. John Joseph Trizzino B.S., M.B.A.", "age": 64, "title": "President & COO", "yearBorn": 1960, "fiscalYear": 2024, "totalPay": 857257, "exercisedValue": 0, "unexercisedValue": 196365}, {"maxAge": 1, "name": "Mr. James Patrick Kelly C.F.A.", "age": 58, "title": "Executive VP, CFO & Treasurer", "yearBorn": 1966, "fiscalYear": 2024, "totalPay": 880849, "exercisedValue": 0, "unexercisedValue": 19825}, {"maxAge": 1, "name": "Mr. Mark J. Casey", "age": 61, "title": "Executive VP, Chief Legal Officer & Corporate Secretary", "yearBorn": 1963, "fiscalYear": 2024, "totalPay": 997654, "exercisedValue": 0, "unexercisedValue": 89347}, {"maxAge": 1, "name": "Ms. Elaine  O'Hara", "age": 56, "title": "Executive VP & Chief Strategy Officer", "yearBorn": 1968, "fiscalYear": 2024, "totalPay": 991316, "exercisedValue": 0, "unexercisedValue": 35053}, {"maxAge": 1, "name": "Mr. Richard P. Crowley", "age": 67, "title": "Executive VP & COO", "yearBorn": 1957, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Troy  Morgan Esq., J.D.", "age": 53, "title": "Senior VP, Deputy General Counsel & Chief Compliance Officer", "yearBorn": 1971, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Erika S. Trahan", "title": "Associate Director of Investor & Public Relations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Ian J. Watkins", "age": 61, "title": "Executive VP & Chief Human Resources Officer", "yearBorn": 1963, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Silvia  Taylor M.B.A.", "title": "Executive VP and Chief Corporate Affairs & Advocacy Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 7, "boardRisk": 6, "compensationRisk": 7, "shareHolderRightsRisk": 5, "overallRisk": 6, "governanceEpochDate": 1746057600, "compensationAsOfEpochDate": 1735603200, "irWebsite": "http://www.novavax.com/go.cfm?do=Stock.GetQuote", "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 5.95, "open": 7.18, "dayLow": 6.48, "dayHigh": 7.5, "regularMarketPreviousClose": 5.95, "regularMarketOpen": 7.18, "regularMarketDayLow": 6.48, "regularMarketDayHigh": 7.5, "payoutRatio": 0.0, "beta": 3.205, "forwardPE": -43.626877, "volume": 30802814, "regularMarketVolume": 30805206, "averageVolume": 5383140, "averageVolume10days": 6398540, "averageDailyVolume10Day": 6398540, "bid": 6.94, "ask": 7.03, "bidSize": 2, "askSize": 2, "marketCap": 1130585216, "fiftyTwoWeekLow": 4.43, "fiftyTwoWeekHigh": 23.86, "priceToSalesTrailing12Months": 1.6585906, "fiftyDayAverage": 6.9936, "twoHundredDayAverage": 9.5758, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 297375968, "profitMargins": -0.27486, "floatShares": 135577182, "sharesOutstanding": 161968000, "sharesShort": 41028051, "sharesShortPriorMonth": 37551429, "sharesShortPreviousMonthDate": 1741910400, "dateShortInterest": 1744675200, "sharesPercentSharesOut": 0.2551, "heldPercentInsiders": 0.087419994, "heldPercentInstitutions": 0.59102, "shortRatio": 7.18, "shortPercentOfFloat": 0.31780002, "impliedSharesOutstanding": 161968000, "bookValue": -3.889, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -187499008, "trailingEps": -1.23, "forwardEps": -0.16, "lastSplitFactor": "1:20", "lastSplitDate": 1557446400, "enterpriseToRevenue": 0.436, "enterpriseToEbitda": -1.621, "52WeekChange": 0.33109617, "SandP52WeekChange": 0.08001411, "quoteType": "EQUITY", "currentPrice": 6.9855, "targetHighPrice": 25.0, "targetLowPrice": 9.0, "targetMeanPrice": 15.57143, "targetMedianPrice": 18.0, "recommendationMean": 2.14286, "recommendationKey": "buy", "numberOfAnalystOpinions": 7, "totalCash": 923118016, "totalCashPerShare": 5.739, "ebitda": -183435008, "totalDebt": 263471008, "quickRatio": 0.893, "currentRatio": 0.978, "totalRevenue": 682161984, "revenuePerShare": 4.482, "returnOnAssets": -0.086339995, "grossProfits": 112522000, "freeCashflow": -175641744, "operatingCashflow": -87263000, "revenueGrowth": -0.697, "grossMargins": 0.16495001, "ebitdaMargins": -0.2689, "operatingMargins": -1.4208901, "financialCurrency": "USD", "symbol": "NVAX", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "regularMarketPrice": 6.9803, "regularMarketChangePercent": 17.30085, "marketState": "REGULAR", "cryptoTradeable": false, "shortName": "Novavax, Inc.", "longName": "Novavax, Inc.", "regularMarketTime": 1746724645, "exchange": "NMS", "messageBoardId": "finmb_350381", "exchangeTimezoneName": "America/New_York", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 5383140, "fiftyTwoWeekLowChange": 2.5503001, "fiftyTwoWeekLowChangePercent": 0.57568854, "fiftyTwoWeekRange": "4.43 - 23.86", "fiftyTwoWeekHighChange": -16.8797, "fiftyTwoWeekHighChangePercent": -0.7074476, "fiftyTwoWeekChangePercent": 33.10962, "dividendDate": 1557446400, "earningsTimestamp": 1746707400, "earningsTimestampStart": 1746707400, "earningsTimestampEnd": 1746707400, "earningsCallTimestampStart": 1746707400, "earningsCallTimestampEnd": 1746707400, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": -1.23, "epsForward": -0.16, "epsCurrentYear": 0.714, "priceEpsCurrentYear": 9.776331, "fiftyDayAverageChange": -0.013299942, "fiftyDayAverageChangePercent": -0.0019017304, "twoHundredDayAverageChange": -2.5955, "twoHundredDayAverageChangePercent": -0.27104786, "priceToBook": -1.794883, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "2.1 - Buy", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 818173800000, "regularMarketChange": 1.0303001, "regularMarketDayRange": "6.48 - 7.5", "corporateActions": [], "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "displayName": "Novavax", "trailingPegRatio": null, "__fetch_time": "2025-05-08"}]